Speakers
You are viewing the 2024 line-up. If you have a compelling case study and would like to join our speaker list for the upcoming event, we would love to hear from you! Please email Chris Clarke at [email protected]
-
James Krikorian
VP, treasurer,
Krispy Kreme
-
Mandana Sadigh
SVP and treasurer,
Mattel Inc.
-
Victor Pausin
Treasurer – Americas,
Nissan Motors Limited
-
Lizette Gracida
Senior director of institutional affairs and foreign trade,
Toyota de México
-
Doug Tropp
SVP and treasurer,
Booking Holdings Inc.
-
Todd Yoder
EVP and chief financial officer,
S&B USA
-
Mack Makode
VP, treasurer,
Under Armour
-
Tamara Saront-Eisner
Treasure
r and vice president, mergers and acquisitions, Americas Hub, Air Liquide
-
Tai Carr-Fraser
Senior director, assistant treasurer,
Capri Holdings Limited -
AnaCarla Costa
Director, global capital markets and Americas treasurer,
Amcor Plc
-
Mike Giakoumatos
VP, treasurer,
Perry Ellis International
-
ShinYoung Park
Assistant treasurer,
Henry Schein, Inc
-
Vincent Joseph
Assistant treasurer – capital and liquidity,
TechnipFMC -
Tim Kolenda
Regional treasurer, North America,
AbbVie
-
Patrick Baumann
VP treasurer,
Signature Aviation
-
Daniel Fleming
VP assistant treasurer,
Circana
-
Ivan Troufanov
VP, treasurer,
Celonis, Inc.
-
Daniel Verwholt
Senior vice president and treasurer,
Air Lease Corporation
-
Arijit Dasgupta
Assistant treasurer
Viatris
-
Maria Claudia Mejia Mesa
Finance control director,
Grupo Levapan
-
Samuel Vallotton
VP, treasury
Salesforce
-
Raul Sanchez
Director treasury,
Mitel
-
Mari Jõgila
Director treasury operations,
Circle K Europe
-
Lisa Killer
Director treasury operations
Orlando Health
-
Jennifer Schumacher
Director, treasury,
Prologis
-
Cesar Falla Olivo
Corporate treasurer and finance manager,
Grupo Gloria
-
Pamela Potrie
Latam finance senior director,
PedidosYa / Delivery Hero
-
Amy Lainge
Head of global treasury operations,
Warner Bros. Discovery
-
Ravi Patel
Director of financial risk management,
Bristol Myers Squibb -
Abhishek Jhunjhunwala
Director of capital markets,
Bristol Myers Squibb